Biospecimen & Biomarker Services To Advance SARS-CoV-2 Research

SARS-CoV-2, the novel coronavirus that causes COVID-19, has exacted an enormous toll across the world, causing severe disease, death, and disruptions to society. In an effort to track, mitigate, and control the impact of the virus, unprecedented global scientific efforts have been initiated to develop new diagnostics, targeted therapies, and vaccines.

Discovery Life Sciences is on the forefront of the global scientific fight, providing biospecimens and biomarker data to help scientists understand the virus itself, such as how it spreads, infects, and evolves new variants, as well as helping researchers develop and validate new diagnostic tests, vaccines and therapies.